Combination of oligofructose and metformin alters the gut microbiota and improves metabolic profiles, contributing to the potentiated therapeutic effects on diet-induced obese animals
And it remains far from pharmaceutical marketing: Phase 3 trials are underway, the target NDA is Q4 2026, and patient access is theoretically not expected before 2028-2029
GLP-1 (glucagon-like peptide-1) is a hormone produced in the intestines that is vital for regulating blood sugar levels and appetite
However, delivery across the blood-brain barrier remains a major challenge requiring innovative approaches
This hormone helps the body release insulin, slows digestion, and reduces appetite
I once tried oral glutathione supplements to calm down a psoriasis flare, only to have the flare get worse